Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal food, Drug, and Coametic Act: Guidance for Industry
Eli Lillys orforglipron, a second type of GLP-1 pill, is still completing phase three trials, with results expected in the first quarter of 2026
IPAMORELIN THERAPY OPTION Ipamorelin is a pentapeptide comprised of amino acids and acts as a GHRP (Growth Hormone Releasing Peptide) In contrast to our typical GHRPs used with Sermorelin, Ipamorelin does not significantly boost, cortisol, aldosterone, or acetylcholine levels
But the KFF Employer Health Benefits Survey shows that even though employers who said they offered obesity drug coverage grew from 18% in 2024 to 19% in 2025, those that said they didn't offer it also increased from 52% to 57% over the same period
MK677: Stimulates growth hormone production, aiding muscle growth, fat loss, improved sleep, and faster recovery
Note on amyloid aggregation: Cagrilintide has proline substitutions at positions 25, 28, 29 , which dramatically reduce the amyloidogenic potential